{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:56:31Z","timestamp":1790776591445,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate perioperative and oncologic outcomes after radical nephrectomy with inferior vena cava (IVC) thrombectomy for renal cell carcinoma (RCC) with venous tumor thrombus, and to assess whether survival relates more to thrombus extent or tumor biology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This prospective cohort study enrolled 46 patients with RCC and IVC tumor thrombus treated between 2019 and 2022; the last follow-up was March 2025. The primary endpoints were overall survival (OS) and cancer-specific survival (CSS), estimated using Kaplan\u2013Meier analysis and exploratory univariate Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Median age was 59.5 years; 36 of 46 were male. Thrombus level was Mayo I in 17, II in 20, III in 7, and IV in 2; 8 had pM1, and 7 had pN1 disease. Median follow-up was 24 months; 26 patients were alive, 18 had died, and 2 were lost to follow-up. 1- and 3-year OS were 78% and 50% (extrapolated); 3-year CSS was approximately 60%. Median OS was 36 months in non-metastatic (n = 38) versus 10 months in metastatic patients (n = 8) (P &lt; 0.001). Nodal involvement (Hazard Ratio [HR] 2.8, P = 0.03) and metastasis (HR 5.1, P = 0.001) predicted poor survival; thrombus level was not associated with OS or CSS (P = 0.65). R0 resection was achieved in 44 of 46 patients. Complications occurred in 7 patients (1 major), with 2 perioperative deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this small prospective cohort, metastatic and nodal status, rather than thrombus extent, were associated with survival, though limited sample size precludes definitive conclusions. Thrombus level affected surgical complexity but not OS or CSS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/iju.iju_121_26","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:00:19Z","timestamp":1790758819000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Reassessing prognosis in renal cell carcinoma with venous tumor thrombus: Prospective data from 46 cases"],"prefix":"10.4103","volume":"42","author":[{"given":"Vivek","family":"Meyyappan","sequence":"first","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Manilal","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaresh","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Janaki","family":"Kavasseri","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Balagangatharan","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lohith","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelanolla Bhasker","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kharade","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Vishal","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavyadeep","family":"Korrapati","sequence":"additional","affiliation":[{"name":"Department of Urology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20260930","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.21037\/cdt.2017.09.16","article-title":"Tumor thrombus: Incidence, imaging, prognosis and treatment","volume":"7","author":"Quencer","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"R2-20260930","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology guidelines on renal cell carcinoma: The 2019 Update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"R3-20260930","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.juro.2007.03.121","article-title":"Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy","volume":"178","author":"Blute","year":"2007","journal-title":"J Urol"},{"key":"R4-20260930","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1464-410X.1987.tb04832.x","article-title":"Surgical treatment of renal cancer with vena cava extension","volume":"59","author":"Neves","year":"1987","journal-title":"Br J Urol"},{"key":"R5-20260930","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.juro.2007.05.134","article-title":"Prognostic factors for renal cell carcinoma with tumor thrombus extension","volume":"178","author":"Klatte","year":"2007","journal-title":"J Urol"},{"key":"R6-20260930","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20260930","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12885-021-08508-x","article-title":"Outcomes of renal cell carcinoma with associated venous tumor thrombus: Experience from a large cohort and short time span in a single center","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"R8-20260930","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-014-1276-7","article-title":"Clinical management of renal cell carcinoma with venous tumor thrombus","volume":"32","author":"Agochukwu","year":"2014","journal-title":"World J Urol"},{"key":"R9-20260930","doi-asserted-by":"crossref","first-page":"52","DOI":"10.22465\/juo.234600600030","article-title":"Prognostic factors and cancer-specific survival of surgically managed renal cell carcinoma with venous thrombus: A 30-year experience at a tertiary referral center","volume":"22","author":"Lee","year":"2024","journal-title":"J Urol Oncol"},{"key":"R10-20260930","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/ua.ua_113_23","article-title":"Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients","volume":"16","author":"Miranda","year":"2024","journal-title":"Urol Ann"},{"key":"R11-20260930","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1464-410X.2004.04897.x","article-title":"The Mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus","volume":"94","author":"Blute","year":"2004","journal-title":"BJU Int"},{"key":"R12-20260930","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.ju.0000108842.27907.47","article-title":"Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?","volume":"171","author":"Moinzadeh","year":"2004","journal-title":"J Urol"},{"key":"R13-20260930","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eururo.2009.06.009","article-title":"Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: Single-center experience","volume":"57","author":"Ciancio","year":"2010","journal-title":"Eur Urol"}],"container-title":["Indian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.iju_121_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:05:46Z","timestamp":1790773546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.iju_121_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/iju.iju_121_26","relation":{},"ISSN":["0970-1591","1998-3824"],"issn-type":[{"value":"0970-1591","type":"print"},{"value":"1998-3824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2026-03-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}